glp 1 weight watchers Releases GLP-1 Results Report Demonstrating 61% Greater Weight Loss This is the result of

A double-blind, randomized, placebo-controlled trial demonstrated that perioperative high-dose intravenous injection of Gln (0.5 g/kg/day, P.O for 3 days) raised plasma Gln concentrations and maintained plasma GSH levels in postoperative patients undergoing cardiopulmonary bypass (CPB) [113]

Role of the gut microbiome for cancer patients receiving immunotherapy: dietary and treatment implications

doi: 10.1016/j.clinthera.2017.05.354 79 LeonNLaCoursiereRYaroshDPatelRS

These results were consistent at 1-, 3-, 5-, and 7-years post index event

PMID: 34626851 Dungan K, DeSantis A (2016): Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus

Gastroenterology 131 , 15531560 (2006)